rare genetic refraction anomaly
ORPHA: 1836011 Treatment Available
Overview
human disease
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| atropine sulfate | ophthalmic solution 0.5%, 1% | FDA Approved | 7 | 7d |
Classification & Codes
Orphanet Code
ORPHA:183601rare genetic refraction anomaly
| Orphanet | ORPHA:183601 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO